Australian cancer patients to access life extending overseas clinical trials in major breakthrough

Google+ Pinterest LinkedIn Tumblr +

crowd of hands_patient selection concept_oncology news australia_800x500By Sue Dunlevy – Herald Sun.

IN a breakthrough that could extend hundreds of lives, cancer patients denied access to new drugs will take part in clinical trials normally closed to Australians.

Most major clinical trials are co-ordinated by international research groups who don’t have any funding to extend their trials to Australia. Australians often miss out on trials of breakthrough new medicines because researchers here don’t have funding for the $5,000 per person cost of running the trial.

The Leukaemia Foundation is about to change that. The charity has partnered with the nation’s leading blood cancer clinical trial group — the Australasian Leukaemia & Lymphoma Group (ALLG) to establish the Trials Enabling Program

Around 125 Australian blood cancer patients will have the costs of trialling new treatment funded by the Leukaemia Foundation over the next two years… read more.

Share.

About Author

ONA Editor

The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.

Comments are closed.